US Patent

US11628088 — Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection

Formulation · Assigned to Bayer Oy · Expires 2027-02-07 · 1y remaining

Vulnerability score 51/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an ultrasonically detectable intrauterine system with an inert metal coating or metal components for enhancing ultrasound detection.

USPTO Abstract

The present invention relates to ultrasonically detectable intrauterine systems and to a method for enhancing ultrasound detection of these systems. An intrauterine system having an inert metal coating on at least part of the body of the intrauterine system or at least one inert metal clip, pin, ring or sleeve fixedly positioned on the body of the intrauterine system is described.

Drugs covered by this patent

Patent Metadata

Patent number
US11628088
Jurisdiction
US
Classification
Formulation
Expires
2027-02-07
Drug substance claim
No
Drug product claim
Yes
Assignee
Bayer Oy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.